SAGE
SAGE Therapeutics Inc
Price:  
5.73 
USD
Volume:  
563,580.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAGE Relative Valuation

-2970.2%
Upside

As of 2024-11-14, the Relative Valuation of SAGE Therapeutics Inc (SAGE) is (164.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.73 USD, the upside of SAGE Therapeutics Inc based on Relative Valuation is -2970.2%.

The range of the Relative Valuation is (168.77) - (172.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.6x - 46.5x 38.3x
Forward P/E multiples 21.3x - 31.3x 21.3x
Fair Price (168.77) - (172.74) (164.46)
Upside -3045.4% - -3114.7% -2970.2%
5.73 USD
Stock Price
(164.46) USD
Fair Price

SAGE Relative Valuation - Historical P/E Data

Date P/E
2024-11-08 -1.14
2024-11-07 -1.15
2024-11-06 -1.08
2024-11-05 -1.08
2024-11-04 -1.05
2024-11-01 -1.10
2024-10-31 -1.10
2024-10-30 -1.17
2024-10-29 -1.54
2024-10-28 -1.55
2024-10-25 -1.45
2024-10-24 -1.42
2024-10-23 -1.39
2024-10-22 -1.39
2024-10-21 -1.41
2024-10-18 -1.37
2024-10-17 -1.31
2024-10-16 -1.32
2024-10-15 -1.24
2024-10-14 -1.23
2024-10-11 -1.19
2024-10-10 -1.15
2024-10-09 -1.18
2024-10-08 -1.17
2024-10-07 -1.22
2024-10-04 -1.20
2024-10-03 -1.27
2024-10-02 -1.26
2024-10-01 -1.26
2024-09-30 -1.31
2024-09-27 -1.32
2024-09-26 -1.30
2024-09-25 -1.27
2024-09-24 -1.32
2024-09-23 -1.31
2024-09-20 -1.36
2024-09-19 -1.43
2024-09-18 -1.38
2024-09-17 -1.36
2024-09-16 -1.37
2024-09-13 -1.42
2024-09-12 -1.33
2024-09-11 -1.36
2024-09-10 -1.33
2024-09-09 -1.35
2024-09-06 -1.36
2024-09-05 -1.38
2024-09-04 -1.45
2024-09-03 -1.43
2024-08-30 -1.53